ArticleJournal of clinical medicine2024

Stratifying the Risk of Disease Progression among Surgically Treated Muscle-Invasive Bladder Cancer Eligible for Adjuvant Nivolumab.

Rocco Simone Flammia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.